Patent applications and USPTO patent grants for Orient Pharma Co., Ltd..The latest application filed is for "solid oral pharmaceutical composition".
Patent | Date |
---|---|
Solid Oral Pharmaceutical Composition App 20220047547 - CHEN; Chien-Yu ;   et al. | 2022-02-17 |
Multi-layer Capsule And Manufacture Method Thereof App 20160228332 - GOTO; Ikuo ;   et al. | 2016-08-11 |
Multi-layer Capsule And Manufacture Method Thereof App 20150174009 - Goto; Ikuo ;   et al. | 2015-06-25 |
Stable Formulations Of Pitavastatin App 20130310420 - Hsiao; Yu-Chien ;   et al. | 2013-11-21 |
Combination Of Alpha-2 Receptor Agonist (clonidin) And Anti-muscarinic Agent (oxybutynin) For The Treatment Of Sialorrhoea App 20120316213 - Roach; Alan Geoffrey ;   et al. | 2012-12-13 |
Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds App 20090297591 - Chiang; Chin-Chih ;   et al. | 2009-12-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.